Theravance Biopharma (TBPH) Equity Income (2018 - 2022)
Powered by 
Analysis
Theravance Biopharma (TBPH) Equity Income (2018 - 2022) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | 4.08 Mn |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | - |
| 10 | Theravance Biopharma | 882.47 Mn | 494.82 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2022 | 28.13 Mn |
| Mar 31, 2022 | 25.11 Mn |
| Dec 31, 2021 | 35.31 Mn |
| Sep 30, 2021 | 30.21 Mn |
| Jun 30, 2021 | 21.93 Mn |
| Mar 31, 2021 | 16.55 Mn |
| Dec 31, 2020 | 20.14 Mn |
| Sep 30, 2020 | 13.40 Mn |
| Jun 30, 2020 | 21.38 Mn |
| Mar 31, 2020 | 13.52 Mn |
| Dec 31, 2019 | 11.91 Mn |
| Sep 30, 2019 | 7.20 Mn |
| Jun 30, 2019 | 8.37 Mn |
| Mar 31, 2019 | 6.23 Mn |
| Dec 31, 2018 | 5.43 Mn |
| Sep 30, 2018 | 3.12 Mn |
| Jun 30, 2018 | 1.95 Mn |
| Mar 31, 2018 | 686,000.00 |